Catalog Number DF105A SMN 10483822 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 04/08/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
Siemens healthcare diagnostics headquarters support center (hsc) concluded their investigation of the discordant, falsely elevated hemoglobin a1c (hb1c) results.The siemens hb1c assay is cleared for monitoring diabetic therapy and not for use in the diagnosis of diabetes.All hb1c assay results processed by the dimension exl 200 instrument were within the instructions for use reference range for adults without suspected diabetes.The customer using the hb1c assay beyond what it is cleared for or beyond the hb1c assay intended use is not supported by siemens.The issue was caused by customer user error.No product non-conformance was identified.The device is performing within specifications.No further evaluation is required.
|
|
Event Description
|
Discordant, falsely elevated hemoglobin a1c (hb1c) results were obtained on patient samples on the dimension exl 200 instrument on (b)(6) 2019.The results were reported to the physician (s) and were questioned.The same samples were reprocessed using an alternate methodology on a non-siemens instrument on the same date and lower hemoglobin a1c results were obtained.On (b)(6) 2019, siemens was informed that the physicians (s) regarded the dimension hb1c results as high and started treatment for pre-diabetes.The type of treatment was not specified.There was no alleged patient harm due to the discordant elevated hb1c results or due to the treatment.
|
|
Manufacturer Narrative
|
Original mdr 2517506-2019-00174 was filed 29-apr-2019.Corrected information (06-may-2019): siemens was informed that the correct date of testing for sample id 1017275409 for hb1c is 18-mar-2019.
|
|
Search Alerts/Recalls
|